Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection

被引:62
作者
Caradonna, L
Mastronardi, ML
Magrone, T
Cozzolongo, R
Cuppone, R
Manghisi, OG
Caccavo, D
Pellegrino, NM
Amoroso, A
Jirillo, E
Amati, L
机构
[1] Sci Inst Digest Dis, Immunopathol Lab, Bari, Italy
[2] Sci Inst Digest Dis, Div Gastroenterol, Bari, Italy
[3] Univ Bari, Dept Internal Med Immunol & Infect Dis, Bari, Italy
[4] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy
关键词
D O I
10.2174/1381612024606983
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Endotoxins or lipopolysaccharides (LPS), major components of the cell wall of Gram-negative bacteria, once released from the bacterial outer membrane bind to specific receptors and, in particular, to a membrane-bound receptor, the CD14 (mCD14) and the toll-like receptor 4 present on monocytes/ macrophages. In turn, LPS-activated monocytes/ macrophages release in the host tissue an array of so-called proinflammatory cytokines and, among them, Tumor Necrosis Factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, IL-8 and IL-12 are the major mediators. Before therapy (T-0) and at the end of 6-month interferon (IFN)-alpha/Ribavirin (RIB) treatment (T-6), circulating endotoxin levels were measured in responder and non responder HCV+ patients. At T-0, 57% of the non responders were endotoxin-positive and had, on average, 54 pg/ml of plasma LPS while in 50% of the responder patients endotoxin were found with an average of 29 pg/ml. At T-6, in responders LPS were no longer detectable, while in 42% of the non responders LPS were found (average levels 45 pg/ml). In terms of serum cytokine concentration, at T-6 IFN-gamma levels when compared to those detected at T-0 were increased in both endotoxin-positive and endotoxin-negative patients. However, at T-6 IL-10 concentration was significantly increased only in the group of endotoxin-negative subjects (responder patients), in comparison to T-0 values. The origin of endotoxemia in HCV+ patients seems to be multifactorial, likely depending on impaired phagocytic functions and reduced T-cell mediated antibacterial activity. In these patients, however, one cannot exclude the passage of LPS from the gut flora to the blood stream, owing a condition of altered intestinal permeability. At the same time, a less efficient detoxification of enteric bacterial antigens at the hepatic level should be taken into consideration. Finally, novel therapeutic attempts aimed to neutralize LPS in the host are discussed.
引用
收藏
页码:995 / 1005
页数:11
相关论文
共 71 条
  • [1] The role of Toll-like receptors and MyD88 in innate immune responses
    Akira, S
    Hoshino, K
    Kaisho, T
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 2000, 6 (05): : 383 - 387
  • [2] Amati L, 1999, ITAL J GASTROENTEROL, V31, P313
  • [3] Impairment of phagocytic and T-cell-mediated antibacterial activity and plasma endotoxins in patients with untreated gastrointestinal cancer
    Amati, L
    Caradonna, L
    Greco, B
    Leo, S
    Caccavo, D
    Jirillo, E
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1998, 33 (08) : 847 - 852
  • [4] PATHOGENIC ROLE OF KUPFFER CELL ACTIVATION IN THE REPERFUSION INJURY OF COLD-PRESERVED LIVER
    ARII, S
    MONDEN, K
    ADACHI, Y
    ZHANG, WH
    HIGASHITSUJI, H
    FURUTANI, M
    MISE, M
    FUJITA, S
    NAKAMURA, T
    IMAMURA, M
    [J]. TRANSPLANTATION, 1994, 58 (10) : 1072 - 1077
  • [5] Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
    Baroni, GS
    Pastorelli, A
    Manzin, A
    Benedetti, A
    Marucci, L
    Solfarosi, L
    Di Sario, A
    Brunelli, E
    Orlandi, F
    Clementi, M
    Macarri, G
    [J]. LIVER, 1999, 19 (03): : 212 - 219
  • [6] Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study
    Baudo, F
    Caimi, TM
    de Cataldo, F
    Ravizza, A
    Arlati, S
    Casella, G
    Carugo, D
    Palareti, G
    Legnani, C
    Ridolfi, L
    Rossi, R
    D'Angelo, A
    Crippa, L
    Giudici, D
    Gallioli, G
    Wolfler, A
    Calori, G
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (04) : 336 - 342
  • [7] The neglected role of type I interferon in the T-cell response: Implications for its clinical use
    Belardelli, F
    Gresser, I
    [J]. IMMUNOLOGY TODAY, 1996, 17 (08): : 369 - 372
  • [8] Brade H., 1999, ENDOTOXIN HLTH DIS
  • [9] Lactoferrin-lipid A-lipopolysaccharide interaction: Inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14
    Caccavo, D
    Afeltra, A
    Pece, S
    Giuliani, G
    Freudenberg, M
    Galanos, C
    Jirillo, E
    [J]. INFECTION AND IMMUNITY, 1999, 67 (09) : 4668 - 4672
  • [10] Caradonna L, 2000, AM J GASTROENTEROL, V95, P1495